- ICH GCP
- US Clinical Trials Registry
- Researchers
- Poland
- Neoplasms, Plasma Cell
Medical specialists from Poland tagged as investigators in clinical trials studying Neoplasms, Plasma Cell
Total 13 results
-
Agata TyczynskaSeen in:
- Gdansk, GSK Investigational Site
Trials:- NCT04126200 (Principal Investigator)
- NCT05714839 (Principal Investigator)
Conditions: -
Artur JurczyszynSeen in:
- Krakow, GSK Investigational Site
Trials:- NCT04484623 (Principal Investigator)
Conditions: -
Dominik DytfeldSeen in:
- Poznan, GSK Investigational Site
Trials:- NCT04091126 (Principal Investigator)
- NCT04126200 (Principal Investigator)
Conditions: -
Jacek RolinskiSeen in:
- Lublin, Lubin Region St. Jana z Dukli
Trials:- NCT05879757 (Principal Investigator)
Conditions: -
Jaroslaw CzyzSeen in:
- Bydgoszcz, GSK Investigational Site
- Bydgoszcz, Szpital Uniwersytecki nr 2 im. dr Jana Biziela w BydgoszczyKlinika Hematologii
Trials:- NCT05254743 (Principal Investigator)
- NCT04484623 (Principal Investigator)
-
Krzysztof GiannopoulosSeen in:
- Lubelskie, Lublin, Centrum Onkologii Ziemi Lubelskiej
- Lublin, Centrum Onkologii Ziemi Lubelskiej
- Lublin, GSK Investigational Site
Trials:- NCT04662255 (Principal Investigator)
- NCT04666038 (Principal Investigator)
- NCT05023980 (Principal Investigator)
- NCT04484623 (Principal Investigator)
-
Magdalena DutkaSeen in:
- Gdansk, GSK Investigational Site
- Pomorskie, Gdansk, Uniwersyteckie Centrum Kliniczne
- Pomorskie, Gdańsk, Uniwersyteckie Centrum Kliniczne
Trials:- NCT04662255 (Principal Investigator)
- NCT04666038 (Principal Investigator)
- NCT04484623 (Principal Investigator)
-
Marek HusSeen in:
- Lubelskie, Lublin, Samodzielny Publiczny Szpital Kliniczny Nr 1
- Lublin, GSK Investigational Site
Trials:- NCT04126200 (Principal Investigator)
- NCT05714839 (Principal Investigator)
- NCT05100056 (Principal Investigator)
Conditions: -
Pawel RobakSeen in:
- Lodz, GSK Investigational Site
Trials:- NCT04126200 (Principal Investigator)
Conditions: -
Sebastian Giebel, MDSeen in:
- Gliwice, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch
Trials:- NCT01665014 (Principal Investigator)
Conditions: -
Sebastian GrosickiSeen in:
- Katowice, GSK Investigational Site
- Silesia, Katowice, Pratia Onkologia Katowice
- Śląskie, Katowice, Pratia Onkologia Katowice
Trials:- NCT04126200 (Principal Investigator)
- NCT04442022 (Principal Investigator)
- NCT06097364 (Principal Investigator)
-
Tadeusz RobakSeen in:
- Lodz, GSK Investigational Site
- Łódź, Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Lodzi
- Łódź, Wojewódzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii
Trials:- NCT04662255 (Principal Investigator)
- NCT04965493 (Principal Investigator)
- NCT04666038 (Principal Investigator)
- NCT04484623 (Principal Investigator)
-
Tomasz WrobelSeen in:
- Dolnoslskie, Wroclaw, Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu
- Radeckiego, Wroclaw, Klinika Hematologii, Nowotworów Krwi i Transplantacji Szpiku Uniwersytecki Szpital Kliniczny im. Jana Mikulicza - Radeckiego we Wrocławiu
- Radeckiego, Wrocław, Uniwersytecki Szpital Kliniczny im. Jana Mikulicza
- Wroclaw, GSK Investigational Site
- Wroclaw, Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu
- Wrocław, Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wrocławiu Klinika Hematologii
Trials:- NCT04662255 (Principal Investigator)
- NCT02227251 (Principal Investigator)
- NCT05254743 (Principal Investigator)
- NCT04442022 (Principal Investigator)
- NCT04484623 (Principal Investigator)
- NCT05100056 (Principal Investigator)
Clinical Trials on Neoplasms, Plasma Cell
-
IRCCS Centro di Riferimento Oncologico della BasilicataCelgene CorporationCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Plasma Cell LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRefractory Plasma Cell Myeloma | Plasmacytoma | Recurrent Plasma Cell Myeloma | Plasma Cell LeukemiaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnPlasma Cell Myeloma | Plasma Cell Leukemia in RemissionUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
National Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
Emory UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; National Institutes...CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | ISS Stage III Plasma Cell Myeloma | ISS Stage II Plasma Cell Myeloma | ISS Stage I Plasma Cell MyelomaUnited States
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)TerminatedRefractory Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell Myeloma | DS (Durie/Salmon) Stage I Plasma Cell MyelomaUnited States
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States